A Single Center Registry of Coronary OCT
Sponsor
Hainan People's Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04855500
Collaborator
(none)
200
1
37
5.4
Study Details
Study Description
Brief Summary
This registry started January 1,2020 to collect patients who recieve coronary OCT imaging in Hainan General Hospital.All enrolled patients will receive 1 year followed-up.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
This registry started January 1,2020.Patients >= 18 years old who recieve coronary OCT imaging in Hainan General Hospital are included in current registry.
Study Design
Study Type:
Observational [Patient Registry]
Anticipated Enrollment
:
200 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
A Registry of Coronary Artery Optical Coherence Tomography of Hainan General Hospital
Actual Study Start Date
:
Jan 1, 2020
Anticipated Primary Completion Date
:
Dec 31, 2022
Anticipated Study Completion Date
:
Jan 31, 2023
Outcome Measures
Primary Outcome Measures
- Major adverse cardiac events (MACE) [1 years]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Subjects who recieved intracoronary OCT imaging during cardiac catheterization are eligible for this registry.
Exclusion Criteria:
- None
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Hainan General Hospital | Haikou | Hainan | China | 570311 |
Sponsors and Collaborators
- Hainan People's Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Liao Wang,
Deputy director of Cardiology,
Hainan People's Hospital
ClinicalTrials.gov Identifier:
NCT04855500
Other Study ID Numbers:
- WangLiao002
First Posted:
Apr 22, 2021
Last Update Posted:
Apr 22, 2021
Last Verified:
Apr 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: